Great news Jen mentioned 1 of the patients who survived +14 months in the CHM1101 trial is still alive. The phase 1a data webinar was 23/10/2023, so that patient is still alive after 18.5 months which is outstanding.
https://www.forbes.com/sites/forbeseq/2024/03/01/the-white-house-war-on-glioblastoma/?sh=6c434a9551ae
Glioblastoma is close to the White houses heart, Joe Biden lost a son to this horrendous illness.
On another note it'll be a month this Friday since the 1st patient was treated in the ADVENT-AML trial. I wonder if we'll get some safety news shortly after.
Great news Jen mentioned 1 of the patients who survived +14...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable